Effects of circulating myostatin on skeletal muscle mass in patients undergoing peritoneal dialysis

Effects of circulating myostatin on skeletal muscle mass in patients undergoing peritoneal dialysis - Circulating myostatin in patients undergoing peritoneal dialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019085

Enrollment

Registered

2015-09-21

Start date

2015-09-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endstage kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients who received peritoneal dialysis treatment between December 2011 and August 2015 at Kyushu University hospital

Exclusion criteria

Exclusion criteria: Patients who do not have frozen serum

Design outcomes

Primary

Measure	Time frame
Serum myostatin level	—

Secondary

Measure	Time frame
Skeletal muscle mass	—

Countries

Japan

Contacts

Public ContactShunsuke Yamada

Kyushu University Department of Medicine and Clinical Science

ana65641@nifty.com092-642-5843

Outcome results